文献速递甲状腺疾病

既往外照射放疗暴露未使分化型甲状腺癌患者预后更差

Previous External Beam Radiation Treatment Exposure Does Not Confer Worse Outcome for Patients with Differentiated Thyroid Cancer.
PubMed 文献 · Thyroid · 2017-02-16

研究从1986至2010年3664例分化型甲状腺癌患者数据库中识别116例有头颈部放疗史者,与3509例无放疗史者比较。两组5年疾病特异性生存率分别为97.4%与98.7%(p=0.798),5年无复发生存率分别为97.8%与94.9%(p=0.371),差异均无统计学意义。

要点

  • 有头颈部放疗史的分化型甲状腺癌患者5年疾病特异性生存率为97.4%,无放疗史者为98.7%(p=0.798)。
  • 有放疗史者5年无复发生存率为97.8%,无放疗史者为94.9%(p=0.371)。
  • 有放疗史组男性比例38.8%高于无放疗史组26.9%(p=0.005),年龄大于45岁者比例67.2%高于53.9%(p=0.005)。

核心结论

  • 研究提示,有既往放疗暴露史的分化型甲状腺癌患者预后与无头颈部放疗暴露史者相似。

研究设计与样本

  • 从1986年至2010年收治的3664例分化型甲状腺癌患者机构数据库中识别116例有头颈部放疗史者(RT组)和3509例无放疗史者(No RT组),采用Kaplan-Meier法比较两组疾病特异性生存率和无复发生存率。

主要发现

  • RT组与No RT组中位年龄分别为52岁和47岁,两组中位随访时间均为54个月。
  • RT组男性比例38.8% vs No RT组26.9%(p=0.005),年龄大于45岁者比例67.2% vs 53.9%(p=0.005)。
  • 两组5年疾病特异性生存率分别为97.4% vs 98.7%(p=0.798),差异无统计学意义。
  • 两组5年无复发生存率分别为97.8% vs 94.9%(p=0.371),差异无统计学意义。
  • 其他患者、肿瘤和治疗特征在两组间相似。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Radiation exposure, especially in childhood, is known to increase the risk for the development of thyroid cancer. However, the prognosis of patients with thyroid cancer with a history of radiation treatment exposure remains unclear. METHODS: One hundred and sixteen patients with a previous history of radiotherapy in the head and neck region were identified from an institutional database of 3664 patients with differentiated thyroid cancer treated between 1986 and 2010. Using the Kaplan-Meier method, disease-specific survival and recurrence-free survival were compared between patients with (RT; n = 116) and without (No RT; n = 3509) a prior history of radiation exposure. RESULTS: The median ages of the RT and No RT cohorts were 52 and 47 years. The median follow-up for both groups was 54 months. Patients who had a prior history of radiation treatment exposure were more likely to be male (38.8% vs. 26.9%; p = 0.005) and older than 45 years of age (67.2% vs. 53.9%; p = 0.005). Other patient, tumor, and treatment characteristics were similar between the groups. There was no difference in the five-year disease-specific survival of the RT and No RT patients (97.4% vs. 98.7%; p = 0.798). The five-year recurrence-free survival was also similar between the RT and No RT patients (97.8% vs. 94.9%; p = 0.371). CONCLUSION: The findings suggest that differentiated thyroid cancer patients with a history of prior radiation treatment exposure have similar outcomes to those with no history of head and neck radiation exposure.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Shaha MA, Wang LY, Migliacci JC, et al. Previous External Beam Radiation Treatment Exposure Does Not Confer Worse Outcome for Patients with Differentiated Thyroid Cancer. Thyroid. 2017. PMID: 27855574. doi:10.1089/thy.2016.0303

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。